Yellow Fever Vaccination in Hemodialysis Patients: A Systematic Review

Introduction: Yellow fever is an infectious disease endemic to Africa, and Central and South America with a significant impact on public health, causing outbreaks and epidemics. Clinical manifestations can vary from asymptomatic to more severe and lethal disease outcomes. The primary prevention of yellow fever occurs through the vaccination of individuals, which confers immunity for life. Patients with chronic kidney disease, especially those undergoing dialysis, have low vaccination and seroconversion rates. As mentioned above, this research aimed to perform a systematic review of the yellow fever vaccination protocol in hemodialysis patients. Methods: A systematic review on vaccination against yellow fever in hemodialysis patients using databases, PubMed and Biblioteca Virtual em Saúde (BVS), was performed. For data collection, combinations were made using the following descriptors: protocols, vaccination, yellow fever, kidney dialysis, chronic kidney failure, chronic kidney disease, and group risk included in the title and abstract description. Articles with no subject related to the search were excluded and also if they were duplicated. Results: In this review, 90 scientific articles were identified in both databases. After applying exclusion criteria, a total of 3 articles were selected. Conclusion: We recommend carefully assessing the risk-benefit and contraindications for the patient, emphasizing the risk groups. There is an evident lack of studies on the subject, and there is a need to broaden investigations related toimmunization for patients on dialysis. The review is registered in the PROSPERO system with the number 323550.